Perspectives on the Collaborative Management of Multiple Myeloma
Dr. Beth Faiman from the Cleveland Clinic moderates a roundtable discussion on Perspectives on the Collaborative Management of Multiple Myeloma, held during the 2015 American Society of Hematology Annual Meeting in Orlando, Florida.
Moderator: Beth Faiman, PhD, APN-BC, AOCN
Participants: Sagar Lonial, MD; Ali McBride, PharmD; Joseph Tariman, PhD, ANP-BC
You can view the entire video here, or click on one of the thumbnails below to just watch a short section that is of interest you.
In The News
American Society of Hematology 2016 Annual Meeting
Session 731. Clinical Autologous Transplantation: Results: Clinical Autologous Transplantation in Myeloma I
American Society of Hematology 2016 Annual Meeting
Session 653. Myeloma: Therapy, excluding Transplantation: IMiD/Proteasome Inhibitor Combinations and Maintenance Therapy
American Society of Hematology 2016 Annual Meeting
Abstract 1143: Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages; Results of the Phase III Myeloma XI Study
American Society of Hematology 2016 Annual Meeting
Abstract 673: Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)
In The Literature
Bone Marrow Transplant